I think a big part of that comes down to regulation when it comes to biotech, which, frankly, I think is a good thing. After all, skimping on software (usually)

I think a big part of that comes down to regulation when it comes to biotech, which, frankly, I think is a good thing. After all, skimping on software (usually) won’t kill anyone, but imagine how much worse things could have been with something like Theranos absent regulation.¹ ⸻ 1. For those rushing to point out that regulation didn’t stop Theranos, it might not have kept the fraud from starting, but it did keep it from continuing.